Sex |
|
|
|
p = 0.7 |
Female |
1 (7.1) |
1 (12.5) |
0 (0.0) |
|
Male |
13 (92.9) |
7 (87.5) |
6 (100.0) |
|
Age at diagnosis |
|
|
|
p = 0.1 |
<60 years |
3 (21.4) |
1 (12.5) |
4 (66.7) |
|
≥60 years |
11 (78.6) |
7 (87.5) |
2 (33.3) |
|
Performance status |
|
|
|
p = 0.1 |
ECOG 0 |
14 (100.0) |
6 (75.0) |
6 (100.0) |
|
ECOG 1 |
0 (0.0) |
2 (25.0) |
0 (0.0) |
|
Prognostic stage groups |
|
|
|
p = 0.3 |
Stage 0 |
2 (14.3) |
0 (0.0) |
0 (0.0) |
|
Stage I |
11 (78.6) |
5 (63.5) |
4 (66.7) |
|
Stage II |
1 (7.1) |
3 (37.5) |
2 (33.3) |
|
Tumor location/target treatment volume |
|
|
|
p = 0.4 |
Both vocal cords |
4 (28.6) |
3 (37.5) |
1 (16.7) |
|
Right vocal cord |
4 (28.6) |
2 (25.0) |
0 (0.0) |
|
Left vocal cord |
6 (42.9) |
3 (37.5) |
5 (83.3) |
|
Mean ± SD total radiation dose (Gy) |
64.9 ± 1.7 |
62.4 ± 5.4 |
64.4 ± 1.5 |
p = 0.2 |
Mean ± SD no. of fractions received |
31.2 ± 2.5 |
29.3 ± 4.3 |
29.8 ± 2.5 |
p = 0.3 |
Mean ± SD dose per fraction (Gy) |
2.1 ± 0.1 |
2.2 ± 0.2 |
2.2 ± 0.1 |
p = 0.4 |